Further multivariate analysis showed that CD4/CD8 ratio (OR 1.409, 95% CI 1.045–1.901, p = 0.0254) is likely to be an independent risk factor for bronchiectasis patients complicated with pulmonary embolism. This evidence concerns the gene CD4 and bronchiectasis.